-
News | 2020.04.28
International Network of Pasteur Institutes: deepening the scientific collective strategy
Three years ago, the scientific community of the Institut Pasteur International Network (IPIN) expressed its desire to build a comprehensive strategy in order to strengthen its positioning and establish itself as a global public health authority. The Scientific Steering Committee of the Institut Pasteur International Network(COS-RIIP) was created in August 2019 to help achieve this goal....
-
Article | 2020.08.20
The Carnot Label
Founded in 2006, the Carnot Label, granted by the French government, was designed to develop partnership-based research, meaning research conducted by public laboratories in partnership with socio-economic players, primarily industry (from SMEs to large corporations), to serve their needs.
-
News | 2020.10.15
A Center for Research in Emerging Infectious Diseases, funded by NIH at the Institut Pasteur in Paris
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded 11 grants to establish the Centers for Research in Emerging Infectious Diseases (CREID), including a coordinating center. One of those centers, and the sole center coordinated by a non-American organization, is the Pasteur International Center for Research on Emerging...
-
News | 2021.09.30
An exceptional case of rabies in France transmitted by a bat
On rare occasions in mainland France, a bite or scratch by a bat can transmit a virus capable of causing rabies, as was the case for a patient in 2019. Experts from the National Reference Center for Rabies at the Institut Pasteur contributed to a study on that particular case this year, in cooperation with research teams from the Institut Pasteur and Necker Enfants Malades and Pitié-Salpêtrière...
-
Document de presse | 2022.10.21
SpikImm announces the clinical trials start for SPK001, its monoclonal antibody against SARS-CoV-2
SPK001, the first anti-SARS Cov2 monoclonal antibody candidate of SpikImm, a French biotechnology company founded by Truffle Capital, originally discovered by the Institut Pasteur's Human Immunology Laboratory, directed by Dr. Hugo Mouquet (Inserm Joint Research Unit), has been tested on three initial cohorts of healthy volunteers, and has demonstrated excellent tolerance, in the context of the...
-
News | 2023.02.20
Earthquake in Turkey: the Institut Pasteur sends scientists to support the relief effort
On a visit to the Institut Pasteur, Chrysoula Zacharopoulou, French Minister of State attached to the Minister for Europe and Foreign Affairs, welcomed the Institut Pasteur's decision to send scientists to help with the relief effort following the earthquake in Turkey. In April 2023, Turkey withdrew its request for assistance to the World Health Organization (WHO) for the deployment of...
-
News | 2023.06.21
Malaria: parasite migration strategy revealed
Malaria is a disease transmitted by mosquitoes that are vectors of parasites in the genus Plasmodium. Scientists from the Institut Pasteur, in collaboration with specialized physicists in Brazil and Germany, have elucidated the search strategy used by parasites to reach the bloodstream.
-
News | 2022.02.16
COVID-19: reducing outbreak risk with repeated antigen screening in healthcare facilities
With the emergence of the Omicron variant, healthcare facilities remain highly vulnerable to virus spread. Effective surveillance of viral presence in these facilities is therefore crucial and needs to be adapted according to outbreak risk. Scientists from the Institut Pasteur worked with colleagues to analyze the reactive use of antigen testing in a long-term care facility following a detected...
-
Article | 2024.04.30
Paul-Louis Simond, world traveler working on multiple diseases
A French naval medical officer, Paul-Louis Simond traveled the world and studied many diseases. After heading up a leprosarium in French Guiana from the age of 24, he spent several years in Indochina where he battled smallpox, and then in China.
-
Document de presse | 2024.05.28
AFROSCREEN: a key network for genomic surveillance in Sub-Saharan Africa
Three years after its launch, AFROSCREEN meets all its objectives, developing effective genomic surveillance to tackle epidemics in sub-Saharan Africa The AFROSCREEN project, financed to the tune of €10 million by Agence Française de Développement (AFD), has been working since 2021 to set up or strengthen sequencing platforms and build an operational network for monitoring emerging...